Pilot study of everolimus in the treatment of advanced malignancies in patients with Peutz-Jeghers syndrome

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020451-32

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To determine the efficacy(as measured by objective tumor response) of single agent everolimus in the treatment of advanced malignancies of patients known with PJS


Critère d'inclusion

  • Advanced malignancy of any tumor type, not suitable for surgery at the time of study enter in patients with known Peutz-Jeghers disease (with LKB1 mutation)

Liens